4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine,
AG 1879,
AG1879,
PP2 cpd,
Src family kinase inhibitor PP2,
172889-27-9,
pp2,
PP 2,
1-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
AG 1879,
1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
InSolution™ PP2,
4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine,
AG-1879,
PP 2 (AG 1879),
CHEMBL406845,
CHEBI:78331,
1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine,
AGL 1879,
AK-60369,
3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
C15H16ClN5,
1qpe,
4few,
PBBRWFOVCUAONR-UHFFFAOYSA-N,
AG1879,
Kinome_2000,
2zv9,
BiomolKI_000052,
PP 2 (enzyme inhibitor),
BiomolKI2_000058,
AC1L1J5T,
AC1Q3SH9,
cid_4878,
Oprea1_738267,
BMK1-F4,
BSPBio_001118,
KBioGR_000458,
KBioSS_000458,
ksc-8-108,
MLS000326622,
SCHEMBL375322,
GTPL9404,
CTK4D4399,
KBio2_000458,
KBio2_003026,
KBio2_005594,
KBio3_000855,
KBio3_000856,
AOB6706,
DTXSID60274447,
Bio2_000399,
Bio2_000879,
HMS1362H19,
HMS1792H19,
HMS1990H19,
HMS2182N11,
HMS3267H08,
HMS3403H19,
HMS3652L14,
HMS3676O04,
KUC104577N,
PP2-AG1879,
PP2(AGL 1879),
BCP07605,
EX-A2140,
KS-00001D7F,
ZINC1383151,
8913AA,
ANW-68842,
BDBM50142887,
BS0149,
IN1144,
s7008,
AKOS005078101,
PP2, >=98% (HPLC),
AG 1879,AGL 1879,
CCG-100656,
CS-1663,
MB01880,
1H-pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-,
IDI1_002154,
QTL1_000068,
NCGC00163385-01,
NCGC00163385-02,
NCGC00163385-03,
NCGC00163385-04,
11L-313S,
4CA-1039,
AJ-25408,
BC600367,
HY-13805,
SMR000179218,
AB0179191,
AX8148955,
DB-064881,
RT-015122,
FT-0711433,
SW220209-1,
EC-000.2432,
VU0205247-1,
A22246,
K00048,
J-010858,
BRD-K95785537-001-03-3,
BRD-K95785537-001-04-1,
BRD-K95785537-001-10-8,
1-Bromomethylpentafluorobenzene;Pentafluorobenzyl bromide,
1-tert-butyl-3-(4-chlorophenyl)pyrazolo[4,5-e]pyrimidin-4-amine,
1-(tert-butyl)-3-(4-chlorophenyl)-4-aminopyrazolo[3,4-d]pyrimidine,
4-amino-5-(4-chlorophenyl)-7-(tert-butyl)pyrazolo[3,4-d]pyrimidine,
1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)- (9CI),
1H-Pyrazolo[3,4-d]pyrimidin-4-amine,3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-,
4-AMINO-3-(4-CHLOROPHENYL)-1-(T-BUTYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE,
9-(4-chlorophenyl)-7-tert-butyl-3,5,8-triaza-7-azoniabicyclo[4.3.0]nona-2,4,6,9-tetraen-2-amine,
PP2 cpd,
ISIS-CRP,
D06CIJ,
D0BU5U,
D0T3HJ,
PP-2,
Src family kinase inhibitor PP2,
CID4878,
AR-1C5647,
2,3,4,5,6-Pentafluorobenzyl bromide,
ACN-038134,
A8216,
A12723,
C412373,
1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE,
4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine,
1765-40-8,
37321-09-8,